glp 1 receptor agonists names List History of glucagon-like peptide-1 receptor
Description
Cardiovascular Risks While some GLP-1 drugs improve heart health, patients with existing heart conditions require close monitoring
25 (5), 10751090.e5
2023;12(18):e028409
Current law prohibits Medicare from covering obesity drugs and gives states flexibility to cover weight loss drugs under Medicaid Limitations on coverage for obesity drugs in Medicare and Medicaid mean that millions of people who have obesity and might benefit from taking GLP-1s may be unable to access them unless they are able to pay the full cash price out of their own pockets, which would likely be prohibitive for people with Medicaid who must have low incomes to qualify for the program, as well as for many people on Medicare with low and modest incomes
Despite promising findings, the lack of standardized experimental models and inconsistent GLP-1-RA dosing regimens across studies limits direct comparison and reproducibility
doi: 10.1016/j.hrtlng.2005.04.002
